Kerry Woss, DO
Family Medicine · Clarendon Hills, ILNPI 1073968418
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Pfizer at 57.5% of the total. 2025 is the largest year on record at $181, 6.9 times the $26 reported in 2021.
Across 24 payments — averaging $20.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$288
- Lilly USA, LLC$66
- Novo Nordisk$33
- Radius Health, Inc.$31
- Teva Pharmaceuticals USA, Inc.$26
- BD$25
- plus $33 from 2 others
What the payments were for
- Speaking & faculty fees$255%
- Food & beverage$47795%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 13 | $288 |
| Lilly USA, LLC | 4 | $66 |
| Novo Nordisk | 2 | $33 |
| Radius Health, Inc. | 1 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| BD | 1 | $25 |
| Exact Sciences | 1 | $19 |
| Amgen | 1 | $14 |
How this compares
$502 in reported general payments places this provider in the 60th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 119 | $1,201 |
| Rosuvastatin Calcium | 69 | $542 |
| Lisinopril | 81 | $464 |
| Levothyroxine Sodium | 40 | $438 |
| Amlodipine Besylate | 62 | $341 |
| Escitalopram Oxalate | 21 | $330 |
| Alendronate Sodium | 26 | $252 |
| Gabapentin | 25 | $236 |
| Omeprazole | 20 | $225 |
| Metoprolol Succinate | 24 | $199 |
| Pantoprazole Sodium | 22 | $192 |
| Pravastatin Sodium | 14 | $148 |
| Losartan Potassium | 32 | $132 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $123 |
| Meclizine Hcl | 13 | $109 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Clarendon Hills
- Frank PhillipsChicago$1.6M
- Peter TothSterling$1.4M
- Bradley TorphyChicago$1.3M
- Jeffrey RoyceRockford$890K
- Anthony AuriemmaWestmont$788K
- Manfred ManGurnee$764K
- Barbara BellarOakbrook Terrace$599K
- Bernie RancheroAltamont$533K
- Sandy GibsonChicago$309K
- Mandy GittlerChicago$204K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.